Skip to main content

Pipeline

CERo is building a broad pipeline of CER T-cell products.

Lead program

Our lead program in hematologic malignancies targets an "Eat Me" signal upregulated on B cell and myeloid tumors.

Pipeline
Product Candidates Indications Stages
Home Malignancies
CER-1236
(Lead Program)
Hematology IND-enabling
Solid Tumors
CER-1236 Solid Tumor Pre-Clinical